Genmab — Maj 2023

[Bulder]

https://seekingalpha.com/news/3962692-jnj-stock-posts-complete-remission-bladder-cancer-therapy om forsøget

[Bulder]

Mere her https://www.sciencedirect.com/science/article/pii/S107814392200059X

[Bulder]

Ikke genmab relateret

[bikube]

Øv, den jeg fandt var også fase 1 med kun 17 deltagere.

[ProinvestorNEWS]

Shortpositioner på danske aktier https://www.proinvestor.com/boards/112386

[E_L]

Antibody Architects https://www.youtube.com/watch?v=Yh9SInylMvk

[Solsen]

Genmab vil blive presset hvis CART virkelig vil få et større patientgrundlag end det ser ud til lige nu. JNJ ligner nogen der tror lidt på det https://finance.yahoo.com/news/johnson-johnson-ignites-car-t-181429711.html

[E_L]

Horizon Therapeutics plc Reports First-Quarter 2023 Financial Results
05/03/23 -- TEPEZZA (teprotumumab-trbw) Net Sales of $405.3 Million -- https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-reports-first-quarter-2023-financial

[Bulder]

A bit low isn’t it?

[E_L]

yes. time for Amgen to take over...

[BioShare]

...haha EL

[gentogen]

Jo, men: More recently, the Company has seen the expansion drive positive momentum in the business, including increases in new prescribers, patient enrollment forms and patient starts. As new prescribers and patients work through the reimbursement process, the Company expects a more meaningful impact to net sales later in the year.

[E_L]

Argenx states : initial two targets identified within immunology and cancer (in the collaboration with Genmab )

[gentogen]

Japan Grants Sakigake Designation to Lu AF82422 (Scheme for Rapid Authorization of Unapproved Drugs: accelerating the practical application of unapproved/off-label use of drugs for serious and life-threatening diseases )

[gentogen]

Japan Grants Sakigake Designation to Satralizumab, Lu AF82422 | PHARMA JAPAN

The Ministry of Health, Labor and Welfare (MHLW) on March 24 granted sakigake designation to two API…

PHARMA JAPAN (pj.jiho.jp)

[bibob]

God morgen fra Spanien.

[JKY_VH]

God morgen, håber solen skinner på dig og markedet i dag bibob;-)

[AaBforever]

Det går da meget godt i dag....minus Genmab.

[bibob]

JKY. 08.20. Tak for det. 26 ˚ kl 09.00 er vel ok. håber også markedet stiger i graderne i dag.

[E_L]

new trial by the University of Birmingham (Genmab collaborates) in Relapsed Follicular Lymphoma, containing Epcoritamab + lenalidomide. Interesting how 2 of the experimental arms will open only in 2025 and 2027 with drugs still to be announced. https://clinicaltrials.gov/ct2/show/NCT05848765